{
  "ci_level": 95,
  "qol_12m_label": "12 months",
  "pci_lower": 56,
  "pci_upper": 62,
  "cabg_lower": 37,
  "cabg_upper": 41,
  "pci_n": 456,
  "cabg_n": 454,
  "pci_count_range": "56 to 62",
  "cabg_count_range": "37 to 41",
  "rd_pp": [
    3.25,
    5.45
  ],
  "rd_range_pp": "+3.25 to +5.45",
  "binomial_envelope_pp": [
    -3.46,
    12.09
  ],
  "binomial_range_pp": "-3.46 to +12.09",
  "missing_pp": [
    -7.1,
    12.68
  ],
  "missing_range_pp": "-7.10 to +12.68",
  "feasible_pairs": 35,
  "allocations": 18564,
  "marginal_sets": 4536,
  "small_n_max": 6,
  "all_intermediate_integers_feasible": true,
  "qol": [
    {
      "cohort": "FAME3_no_ACS",
      "time": "baseline",
      "metric": "EQ5D",
      "PCI_mean": 0.821,
      "CABG_mean": 0.82,
      "adjusted_difference": 0.001,
      "lower_95": -0.019,
      "upper_95": 0.02,
      "source": "doi:10.1161/CIRCULATIONAHA.122.060049",
      "locator": "appendix Table S3"
    },
    {
      "cohort": "FAME3_no_ACS",
      "time": "1_month",
      "metric": "EQ5D",
      "PCI_mean": 0.899,
      "CABG_mean": 0.838,
      "adjusted_difference": 0.062,
      "lower_95": 0.042,
      "upper_95": 0.081,
      "source": "doi:10.1161/CIRCULATIONAHA.122.060049",
      "locator": "appendix Table S3"
    },
    {
      "cohort": "FAME3_no_ACS",
      "time": "12_month",
      "metric": "EQ5D",
      "PCI_mean": 0.876,
      "CABG_mean": 0.878,
      "adjusted_difference": -0.004,
      "lower_95": -0.024,
      "upper_95": 0.016,
      "source": "doi:10.1161/CIRCULATIONAHA.122.060049",
      "locator": "appendix Table S3"
    }
  ],
  "economic": {
    "extraction_utc_date": "2026-11-11",
    "scope": "Separate source-based context accompanying the follow-on analysis",
    "qol_source": "https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.060049",
    "qol_appendix": "https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.122.060049/suppl_file/circ_circulationaha-2022-060049_supp1.pdf",
    "qol_visual_source_check": false,
    "economic_source": "https://pubmed.ncbi.nlm.nih.gov/41194756/",
    "economic_access": "Abstract and publisher preview only; no full text or patient records",
    "economic_population": "Overall mixed-presentation FAME3 cohort",
    "CABG_to_PCI_cost_ratio": 1.3,
    "cost_ratio_95": [
      1.16,
      1.46
    ],
    "cost_valuation": "Medicare reimbursement rates applied to resource use",
    "qaly_5y_means": {
      "PCI": 4.05,
      "CABG": 4.03
    },
    "no_significant_qaly_difference_reported": true,
    "employment_5y_baseline_under65_pct": {
      "PCI": 56,
      "CABG": 47
    },
    "independent_patient_level_or_economic_reproduction": false,
    "limits": [
      "No justified clinical equivalence margin",
      "Stable-only economics not reported in retrieved abstract/preview",
      "Unknown cost transferability to other systems",
      "Not a new cohort or independent outcome study"
    ]
  },
  "registry": [
    {
      "nct": "NCT07308860",
      "name": "FAME-3 Extended: longer survival follow-up",
      "source_url": "https://clinicaltrials.gov/study/NCT07308860",
      "retrieved_utc": "2026-11-11T08:59:47.219468+00:00",
      "status": "ACTIVE_NOT_RECRUITING",
      "registry_last_updated": "2025-12-30",
      "enrollment": 1500,
      "enrollment_type": "ACTUAL",
      "primary_completion": "2030-06-30",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Ten-year follow-up of the same 1,500 participants already randomized in FAME-3; the extension record is observational.",
      "endpoint_summary": "Overall survival at ten years.",
      "interpretation": "This is directly relevant to the mortality uncertainty in the main study, if stable-presentation results and follow-up completeness are reported. It adds follow-up time, not another independent randomized cohort. More follow-up does not guarantee adequate precision for a modest clinical margin."
    },
    {
      "nct": "NCT05831085",
      "name": "DEFINE-DM: contemporary PCI in diabetes",
      "source_url": "https://clinicaltrials.gov/study/NCT05831085",
      "retrieved_utc": "2026-11-11T08:59:47.068936+00:00",
      "status": "RECRUITING",
      "registry_last_updated": "2026-06-24",
      "enrollment": 1500,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2029-12-31",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Randomized imaging- and physiology-guided PCI versus standard CABG in people with type 2 diabetes and three-vessel disease; left-main disease is excluded.",
      "endpoint_summary": "Death, MI or stroke at two years.",
      "interpretation": "This tests a newer PCI strategy in an important high-risk group. It is not automatically stable-only: the listed exclusions rule out very recent STEMI but do not exclude every acute presentation. A composite noninferiority result, if reported, would not by itself establish mortality equivalence."
    },
    {
      "nct": "NCT05427370",
      "name": "STICH3C: ischemic ventricular dysfunction",
      "source_url": "https://clinicaltrials.gov/study/NCT05427370",
      "retrieved_utc": "2026-11-11T08:59:47.064222+00:00",
      "status": "RECRUITING",
      "registry_last_updated": "2026-10-19",
      "enrollment": 754,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2029-04",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Randomized PCI versus CABG in patients with ejection fraction at most 40% and multivessel or left-main disease, suitable for both procedures.",
      "endpoint_summary": "Time to death, stroke, spontaneous MI, urgent repeat revascularization or heart-failure readmission, with median follow-up planned at five years.",
      "interpretation": "This addresses ventricular dysfunction rather than the general stable, non-left-main population. Its eligibility and endpoint need to be retained when interpreting eventual results; it cannot simply be pooled with a lower-risk stable subgroup."
    },
    {
      "nct": "NCT07269366",
      "name": "STICH 3.0-NL: related ventricular-dysfunction work",
      "source_url": "https://clinicaltrials.gov/study/NCT07269366",
      "retrieved_utc": "2026-11-11T08:59:47.052844+00:00",
      "status": "RECRUITING",
      "registry_last_updated": "2026-05-12",
      "enrollment": 358,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2034-05",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Randomized CABG versus PCI with ejection fraction at most 40%; multivessel disease may include left-main disease. The summary states participation in the international STICH 3.0 collaboration.",
      "endpoint_summary": "A hierarchical comparison of death, major cardiovascular events and heart-failure admissions at four years.",
      "interpretation": "A hierarchical win-based endpoint is a different estimand from a first-event composite or mortality hazard ratio. Distinct registry records need not represent independent programmes or cohorts; do not sum planned enrollment without resolving collaboration and overlap."
    },
    {
      "nct": "NCT06566183",
      "name": "ISCHEMIA-LVD: includes a medical-therapy arm",
      "source_url": "https://clinicaltrials.gov/study/NCT06566183",
      "retrieved_utc": "2026-11-11T08:59:47.058715+00:00",
      "status": "SUSPENDED",
      "registry_last_updated": "2026-06-05",
      "enrollment": 1200,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2030-12",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "A three-arm randomized registration for guideline-directed medical therapy, CABG and PCI in multivessel disease with ejection fraction at most 40%.",
      "endpoint_summary": "Listed primary measures include cognition, heart-failure health status, and a death/MI/stroke/heart-failure-admission composite at twelve months.",
      "interpretation": "The registry says suspended and temporarily paused. A proposed three-way comparison is not available evidence that one strategy is better, nor a guarantee that the study will start or finish."
    },
    {
      "nct": "NCT01311323",
      "name": "MILESTONE",
      "source_url": "https://clinicaltrials.gov/study/NCT01311323",
      "retrieved_utc": "2026-11-11T08:59:47.230863+00:00",
      "status": "RECRUITING",
      "registry_last_updated": "2026-07-08",
      "enrollment": 1000,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2028-12",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Randomized PCI versus CABG for acute non-ST-elevation coronary syndromes.",
      "endpoint_summary": "One-year endpoints differ; see source registration.",
      "interpretation": "Explicitly excludes stable presentation; adjacent evidence, not a stable-only comparison."
    },
    {
      "nct": "NCT06279663",
      "name": "NSTE-ACSMT",
      "source_url": "https://clinicaltrials.gov/study/NCT06279663",
      "retrieved_utc": "2026-11-11T08:59:47.218114+00:00",
      "status": "RECRUITING",
      "registry_last_updated": "2024-03-13",
      "enrollment": 460,
      "enrollment_type": "ESTIMATED",
      "primary_completion": "2028-12-31",
      "primary_completion_type": "ESTIMATED",
      "design_summary": "Randomized PCI versus CABG for acute non-ST-elevation coronary syndromes.",
      "endpoint_summary": "One-year endpoints differ; see source registration.",
      "interpretation": "Explicitly excludes stable presentation; adjacent evidence, not a stable-only comparison."
    }
  ],
  "registry_n": 7,
  "scope_audit": [
    {
      "record": "PMID25780954",
      "source_url": "https://pubmed.ncbi.nlm.nih.gov/25780954/",
      "initial_census_record": true,
      "initial_decision": "excluded",
      "initial_reason": "secondary_synthesis",
      "indexed_publication_types": [
        "Comparative Study",
        "Journal Article",
        "Review"
      ],
      "clarification": "Original registry comparisons are discussed, but contemporary PCI is compared with historical ERACI-III arms rather than a new contemporary PCI-CABG randomization.",
      "more_informative_reason": "contemporary_stent_registry_and_historical_comparators",
      "eligible_cohort_added": false
    },
    {
      "record": "PMID23428214",
      "source_url": "https://doi.org/10.1016/j.jacc.2012.11.044",
      "registry_url": "https://clinicaltrials.gov/study/NCT00326196",
      "initial_census_record": false,
      "lookup": "Additional post-submission targeted source audit",
      "randomized_denominators": {
        "PCI": 101,
        "CABG": 97
      },
      "published_followup_mean_years": 2,
      "registry_monitoring": "up to 4 years",
      "reported_platform_categories": [
        "Taxus",
        "Cypher",
        "XIENCE/PROMUS",
        "Endeavor",
        "mixed DES",
        "mixed bare-metal stents"
      ],
      "platform_count_warning": "Reported platform categories are not used to infer stent exposure for every randomized participant.",
      "exclusion_reason": "Mixed older and newer platforms; no separately randomized contemporary-platform contrast or eligible stable-only long-term contemporary outcome table established.",
      "eligible_cohort_added": false
    }
  ]
}
